PMID: 7371700Jan 1, 1980

Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine and phenylbutazone in man

European Journal of Clinical Pharmacology
P J Neuvonen, E Elonen

Abstract

No abstract listed.

References

Mar 1, 1978·Clinical Pharmacokinetics·L Bertilsson
Sep 1, 1978·Clinical Pharmacokinetics·J Aarbakke
Oct 1, 1978·Journal of Pharmacokinetics and Biopharmaceutics·S TakkiT N Tozer
Jan 1, 1979·Clinical Toxicology·E ElonenM J Mattila
May 5, 1979·British Medical Journal·E ElonenR Kala
May 1, 1979·Journal of Clinical Pharmacology·C T ViswanathanP G Welling
May 31, 1978·European Journal of Clinical Pharmacology·P J NeuvonenE Elonen
Dec 18, 1978·European Journal of Clinical Pharmacology·S DawlingR A Braithwaite
Jan 1, 1975·Clinical Toxicology·J W Hayden, E G Comstock
Jan 1, 1976·Clinical Pharmacokinetics·W S Nimmo
Jul 21, 1973·Lancet·G HärtelP Reissell
May 1, 1972·Clinical Pharmacology and Therapeutics·G Levy, T Tsuchiya
Nov 1, 1968·Toxicology and Applied Pharmacology·W J DeckerD G Corby

Citations

Jun 1, 1993·Journal of Clinical Pharmacology·S PhillipsJ Brent
Jan 1, 1983·European Journal of Clinical Pharmacology·P J NeuvonenO Tokola
Jan 1, 1983·European Journal of Clinical Pharmacology·P J NeuvonenE L Hirvisalo
Jan 1, 1982·European Journal of Clinical Pharmacology·A J WilenskyS P Kaluzny
Jul 1, 1982·Canadian Anaesthetists' Society Journal·P R GwiltJ J Mitala
Dec 12, 2007·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Trevonne M Thompson, Steven E Aks
Aug 5, 2005·Current Treatment Options in Neurology·Donald M HiltyTaoufik M Alsaadi
May 2, 1987·Lancet·D A BoldyL F Prescott
Mar 16, 2000·British Journal of Clinical Pharmacology·O Lapatto-ReiniluotoP J Neuvonen
Sep 9, 1982·The New England Journal of Medicine·M J BergG F Johnson
Sep 9, 1982·The New England Journal of Medicine·G Levy
Jan 1, 1997·British Journal of Clinical Pharmacology·K LaineP J Neuvonen
Feb 1, 1993·Journal of Clinical Pharmacy and Therapeutics·M A al-MeshalM M al-Dardiri
Jan 1, 1989·Epilepsia·M SethnaH Kutt
Apr 1, 1993·Pharmacology & Toxicology·N M RawashdehA K Battah
Mar 1, 1990·The Journal of Pharmacy and Pharmacology·J D Huang
Aug 1, 1990·The Journal of Pharmacy and Pharmacology·Y M el-Sayed, M M Hasan
May 1, 1987·Antimicrobial Agents and Chemotherapy·R L DavisA L Smith
Feb 1, 1988·Antimicrobial Agents and Chemotherapy·R L DavisA N Smith
Sep 5, 1992·BMJ : British Medical Journal·S W AtkinsonG A Trotter
Jan 9, 1993·BMJ : British Medical Journal·J A Vale, A T Proudfoot
Aug 7, 2002·Clinical Pharmacokinetics·Michael S RobertsMichael Weiss
Nov 28, 2013·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Xiaoli WangCharles Frost
Jan 1, 1984·Drug Metabolism Reviews·Z H Israili, P G Dayton
Dec 1, 1982·Journal of Toxicology. Clinical Toxicology·J R ReigartJ M Lindsey
Jan 1, 1984·Journal of Toxicology. Clinical Toxicology·G de GrootR A Maes
Jan 1, 1985·Journal of Toxicology. Clinical Toxicology·A G Gallanosa, D A Spyker
Jan 1, 1986·Journal of Toxicology. Clinical Toxicology·J A CordonnierA M Heyndrickx
Jan 1, 1987·Journal of Toxicology. Clinical Toxicology·W A WatsonJ J Schentag
Jan 1, 1989·Journal of Toxicology. Clinical Toxicology·F HarchelroadE P Krenzelok
Jan 1, 1991·Journal of Toxicology. Clinical Toxicology·M VeermanM Knight
Jan 1, 1992·Journal of Toxicology. Clinical Toxicology·S WasonR W Druckenbrod
Jan 1, 1996·Journal of Toxicology. Clinical Toxicology·M L FreniaT A Kunisaki
Jan 1, 1994·Journal of Toxicology. Clinical Toxicology·Y WakabayashiT Ohwada
Apr 13, 2005·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·P A ChykaEuropean Association of Poisons Centres and Clinical Toxicologists
Oct 31, 2014·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Marc GhannoumEXTRIP workgroup
Jan 1, 1988·Medical Toxicology and Adverse Drug Experience·P J Neuvonen, K T Olkkola
Dec 17, 2009·Basic & Clinical Pharmacology & Toxicology·Anne-Bolette Jill GudeHanne Rolighed Christensen
May 1, 1992·The American Journal of Emergency Medicine·J W Campbell, P A Chyka
Mar 1, 1988·The American Journal of Emergency Medicine·J B Sullivan, E P Krenzelok
Jan 1, 1992·The Journal of Emergency Medicine·C TomaszewskiK Kulig
Feb 1, 1988·British Journal of Clinical Pharmacology·P J NeuvonenE L Hirvisalo
Feb 1, 1982·Journal of Clinical Pharmacology·E NelsonD Perrier
Apr 1, 1989·Journal of Clinical Pharmacology·J L HoG E Dickinson
Feb 1, 1991·Annals of Emergency Medicine·T A Newton, S R Rose
May 1, 1981·Annals of Emergency Medicine·J M Riegel, C E Becker
May 1, 1991·Annals of Emergency Medicine·M Tenenbein
Jul 11, 2000·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·O E OrisakweC N Orish
Jan 27, 2004·The Annals of Pharmacotherapy·Chie TanakaYasufumi Sawada
Oct 1, 1987·Annals of Emergency Medicine·L S MauroP Somani
Jul 1, 1994·Human & Experimental Toxicology·K LaineP J Neuvonen
Sep 1, 1986·Journal of Pharmaceutical Sciences·J D Huang, M C Tzou
Jun 1, 2000·Annals of Emergency Medicine·B A Wolsey, P E McKinney
Nov 1, 1992·Human & Experimental Toxicology·K LaineP J Neuvonen
May 1, 1985·Human Toxicology·D W DenningJ A Henry
Dec 13, 2017·Current Medical Research and Opinion·Helen Senderovich, Megan J Vierhout
Sep 1, 1986·Biopharmaceutics & Drug Disposition·L J AdlerP R Gwilt
Mar 15, 1980·British Medical Journal·P J Neuvonen, E Elonen
Sep 5, 1992·BMJ : British Medical Journal·I WakabayashiH Masui
Jan 1, 1994·International Ophthalmology·V K GulatiK R Joshi
Jun 1, 1997·Critical Reviews in Food Science and Nutrition·J F Vélez-Ruiz, G V Barbosa Cánovas
Jun 22, 2018·American Journal of Therapeutics·Frank Lee Cantrell, Christie Sun
Jan 1, 1990·The Journal of International Medical Research·F PisaniR Di Perri
Aug 1, 1990·Anaesthesia and Intensive Care·A McLuckieK F Ilett
Jul 1, 1993·The Annals of Pharmacotherapy·P B KaleM J Higgins
Jun 20, 2020·European Journal of Clinical Pharmacology·Hisakazu OhtaniTakeshi Akiyoshi
Jan 1, 1993·Postgraduate Medical Journal·J A Vale
Jan 1, 1995·Journal of Toxicology. Clinical Toxicology·S M Bradberry, J A Vale
Mar 10, 1998·Human & Experimental Toxicology·P BaldrickM L Tattersall
Jul 1, 1987·Postgraduate Medicine·J W Donovan
Apr 1, 1991·DICP : the Annals of Pharmacotherapy·O M ShapiraS Konichezky
May 1, 1986·Human Toxicology·B A HulténT Hedner
Jun 21, 2019·Deutsches Ärzteblatt International·Tobias ZellnerFlorian Eyer
Mar 2, 1992·The Medical Journal of Australia·D JawaryJ J McNeil

Related Concepts

Carbamazepine Sulfate (2: 1)
Actidose
Intestinal Absorption
Luminal
Fenilbutazon

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Systemic Juvenile Idiopathic Arthritis

Systemic juvenile idiopathic arthritis is a rare rheumatic disease that affects children. Symptoms include joint pain, as well as fevers and skin rashes. Here is the latest research on this disease.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Cell Atlas Along the Gut-Brain Axis

Profiling cells along the gut-brain axis at the single cell level will provide unique information for each cell type, a three-dimensional map of how cell types work together to form tissues, and insights into how changes in the map underlie health and disease of the GI system and its crosstalk with the brain. Disocver the latest research on single cell analysis of the gut-brain axis here.

Myocardial Stunning

Myocardial stunning is a mechanical dysfunction that persists after reperfusion of previously ischemic tissue in the absence of irreversible damage including myocardial necrosis. Here is the latest research.

Pontocerebellar Hypoplasia

Pontocerebellar hypoplasias are a group of neurodegenerative autosomal recessive disorders with prenatal onset, atrophy or hypoplasia of the cerebellum, hypoplasia of the ventral pons, microcephaly, variable neocortical atrophy and severe mental and motor impairments. Here is the latest research on pontocerebellar hypoplasia.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.

Trichotillomania

Trichotillomania is an impulse control disorder characterized by the recurrent pulling of one's hair resulting in noticeable hair loss. Here are the latest discoveries in this field.

DDX3X Syndrome

DDX3X syndrome is caused by a spontaneous mutation at conception that primarily affects females due to its location on the X-chromosome. DDX3X syndrome has been linked to intellectual disabilities, seizures, autism, low muscle tone, brain abnormalities, and slower physical developments. Here is the latest research.